In this video Professor Campisi talks about the trial of UB1325 from Unity Biotech and some of the most exciting technologies in the aging field.

The Campisi lab at the Buck Institute
[ Ссылка ]

Judith Campisi is a professor of biogerontology at the Buck Institute for Research on Aging. She is co-editor in chief of the Aging Journal, and founder of the pharmaceutical company Unity Biotechnology. Prof Campisi is widely recognized for her work on senescent cells and their influence on many manifestations of aging. Her laboratory discovered Senescence Associated Secretory Phenotype (SASP) and also discovered the first non-invasive biomarker to verify the efficacy of senolytics.

********************************************************************
Health claims Disclosure: Information provided on this video is not a substitute for direct, individual medical treatment or advice. Please consult with your doctor first. Products or services mentioned in this video are not a recommendation.

Audio Copyright Disclaimer:
Please note that we have full authorization to the music that we used in our videos as they were created using the service WeVideo which provides the rights to the music. The rights are detailed in the terms of use that can be reviewed here [ Ссылка ] and any following inquiries should be addressed to legal@wevideo.com.

*************************************************************************
If you would like to support our channel, we’d love a coffee…thank you! [ Ссылка ]

#JudithCampisi #unitybiotech #ubx1325 #maculardegeneration #healthspan #senescentcells #lifestyles #senolytics #biomarker #immune #immunesystem #senescence #modernhealthspan #healthspan #lifespan #health #longevity #BuckInstitute #JudithCampisi #ProfCampisi #Senolytics #SASP #DavidSinclair #JamesKirkland #research

свернуть